Please use this identifier to cite or link to this item: http://hdl.handle.net/10668/10935
Title: Vestibular paroxysmia: Diagnostic criteria.
Authors: Strupp, Michael
Lopez-Escamez, Jose A
Kim, Ji-Soo
Straumann, Dominik
Jen, Joanna C
Carey, John
Bisdorff, Alexandre
Brandt, Thomas
Keywords: ICVD;Vertigo;attacks;dizziness;neurovascular compression
metadata.dc.subject.mesh: Benign Paroxysmal Positional Vertigo
Carbamazepine
Diagnosis, Differential
Female
Head Movements
Humans
Magnetic Resonance Imaging
Male
Otologic Surgical Procedures
Oxcarbazepine
Prevalence
Vertigo
Vestibular Diseases
Vestibular Function Tests
Vestibulocochlear Nerve
Issue Date: 2016
Abstract: This paper describes the diagnostic criteria for vestibular paroxysmia (VP) as defined by the Classification Committee of the Bárány Society. The diagnosis of VP is mainly based on the patient history and requires: A) at least ten attacks of spontaneous spinning or non-spinning vertigo; B) duration less than 1 minute; C) stereotyped phenomenology in a particular patient; D) response to a treatment with carbamazepine/oxcarbazepine; and F) not better accounted for by another diagnosis. Probable VP is defined as follows: A) at least five attacks of spinning or non-spinning vertigo; B) duration less than 5 minutes; C) spontaneous occurrence or provoked by certain head-movements; D) stereotyped phenomenology in a particular patient; E) not better accounted for by another diagnosis.Ephaptic discharges in the proximal part of the 8th cranial nerve, which is covered by oligodendrocytes, are the assumed mechanism. Important differential diagnoses are Menière's disease, vestibular migraine, benign paroxysmal positional vertigo, epileptic vestibular aura, paroxysmal brainstem attacks (in multiple sclerosis or after brainstem stroke), superior canal dehiscence syndrome, perilymph fistula, transient ischemic attacks and panic attacks. Current areas of uncertainty in the diagnosis of VP are: a) MRI findings of vascular compression which are not diagnostic of the disease or predictive for the affected side because they are also observed in about 30% of healthy asymptomatic subjects; and b) response to treatment with carbamazepine/oxcarbazepine supports the diagnosis but there are so far no randomized controlled trials for treatment of VP.
URI: http://hdl.handle.net/10668/10935
metadata.dc.identifier.doi: 10.3233/VES-160589
Appears in Collections:Producción 2020

Files in This Item:
File SizeFormat 
PMC9249278.pdf69,22 kBAdobe PDFView/Open


This item is protected by original copyright



Except where otherwise noted, Items on the Andalusian Health Repository site are licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives License.